“Latest Stem Cells News”

The use of stem cells has often been a controversial issue in the media. International Stem Cell Corp. looks set to tackle the issue head on after launching its own line of stem cell based beauty products. According to reports online the skin care range was created by its wholly owned subsidiary Lifeline Skin Care.

CEO of Lifeline Skin Care, Dr. Ruslan Semechkin, was quoted as saying, “The commercial launch of the new skin care products represents an important step in the execution of ISCO`s strategy.” Plastic surgeon Dr. Gregory S. Keller described the new range as “…a huge step forward in anti-aging skin care products”.

International Stem Cell Corp is based in California. Lifeline skin care develops cosmetics using contain extracts from human parthenogenetic stem cells. The product range includes Defensive Day Moisture Serum and Recovery Night Moisture Serum.

from http://www.carefair.com/html/Stem_Cell_Based_Cosmetics_Launched_10469.html

Incoming search terms:

A revolutionary stem cell procedure may be able to stop ALS, or Lou Gehrig‘s disease, in its tracks.

HealthFirst reporter Leslie Toldo shares the story of one of the few people who have had it done.
ALS is a deadly disease, with a quick and devastating decline. This could be the hope thousands of people have been waiting for.

Fifty-five-year-old Tom Elliott is not a quitter. He has ALS and fights to keep up with the daily routines of his life, even as the disease makes everything harder. “Brushing the teeth has become a real chore. Turning and rolling in bed to get comfortable has become an impossibility. This disease is about having to give up and sacrifice a lot.”

As ALS progresses, it destroys the nerve cells in the brain and spinal cord that control muscle movement until people “cease to be able to move, they become essentially locked in their bodies,” Dr. Nicholas Boulis said.

Incoming search terms:

Scientists in the US have made a major breakthrough that has the potential for people with brain damage, caused by epilepsy or Parkinson’s for example, to use their own brain stem cells as a treatment.

Steven Roper of the University of Florida discovered that stem cells from the human brain that were transplanted into the brains of newborn rats matured and were able to function just like native rat cells.

The researchers found that the adult stem cells had the ability to turn into all types of brain tissue in the rats, including the neocortex, which deals with higher processing, and the hippocampus, involved in memory and spatial awareness.

Incoming search terms:

Muscle wasting linked to old age might one day be treated using stem cells, claim US scientists.

A University of Colorado team transplanted cells into mice and saw the muscle more than double in size - staying that way even into old age.

They say their work, reported in Science Translational Medicine, may have promise in treating muscle-wasting conditions such as muscular dystrophy.
A UK expert said producing a human treatment might be difficult.
Stem cells are cells found in the body which can divide and become a variety of different types of tissue.

Scientists believe they could potentially help treat a large number of problems by helping to re-populate areas of tissue damaged by disease or injury.

A common problem in older people is muscle weakness, linked to a loss of muscle mass in the arms and legs.
This can lead to a swift fall in the quality of life for older people and in some cases increase the need for extra care and support.

Incoming search terms:

Scientists have identified a way of prompting nerve system repair in multiple sclerosis (MS).

Studies on rats by Cambridge and Edinburgh University researchers identified how to help stem cells in the brain regenerate myelin sheath, needed to protect nerve fibres.
MS charities said the “exciting” Nature Neuroscience work offered hope of restoring physical functions.

But they cautioned it would be some years before treatments were developed.
MS is caused by a defect in the body’s immune system, which turns in on itself, and attacks the fatty myelin sheath.

It is thought to affect around 100,000 people in the UK.
Around 85% have the relapsing/remitting form of the condition, in which “flare-ups” which cause disability, are followed by a recovery of a level of the lost physical function.

In this form of MS, there does appear to be some natural myelin repair.
However, around 10% of people are diagnosed with a progressive form of MS, where the decline continues without any periods of remission.

Incoming search terms: